B12 deficiency elevates homocysteine, a sulfur-containing amino acid that damages arterial endothelium and increases atherosclerosis risk
Tirzepatide demonstrated superior weight loss outcomes
MMs with KIT mutations presumably affect the function of juxta-membrane autoinhibitory domain (JMD) (W557R, N566D, V559A, V559D, V560D, V569G, P573L, L576P, K642E) and tyrosine kinase domains (D816H, D820Y, A829P, N822K), causing constitutive activation of C-KIT-regulated pathways (8184)
The SURMOUNT-1 trial showed 22.5 percent body weight reduction with 15 mg tirzepatide at 72 weeks, compared to approximately 15 percent with semaglutide 2.4 mg in the STEP trials
The ADA/EASD recently published a 2019 update to the 2018 consensus report
Of these, dyslipidemia has emerged as the primary factor involved in the development of small fiber neuropathy, via an inflammatory pathway or oxidative stress mechanism